All Posts: non-small cell lung cancer

Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations

Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung…

November 8, 2024